Sustained increases in FIX activity after etranacogene dezaparvovec administration. Uncontaminated FIX activity measured by using a 1-stage aPTT assay. ∗Samples at baseline and Week 1 may have included activity from exogenous FIX replacement. aPTT, activated partial thromboplastin time.